Michael Steinmetz
CIK 1166285 · last filed 2015-08-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TLOG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VBI VACCINES INC. (VBIV) Delisted | Director | — | $0.07 | — | $0 | 1 | 2015-08-05 |
| IVERIC bio, Inc. (OPHT) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2015-05-28 |
| TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted | Director | 4,621,423 | — | — | $89.78M | 2 | 2015-01-30 |
| AERIE PHARMACEUTICALS INC (AERI) Delisted | 10%+ Owner | 3,332,306 | $15.25 | $50.82M | $28.89M | 1 | 2013-10-28 |
| Radius Health, Inc. (RDUS) Delisted | 10%+ Owner | — | $30.00 | — | $0 | 1 | 2013-04-30 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | 10%+ Owner | 12 | — | — | $0 | 1 | 2010-12-07 |
| ReShape Weightloss Inc. (ETRM) Delisted | 10%+ Owner | 965,140 | — | — | $12.18M | 2 | 2010-10-04 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | 5,364,572 | — | — | $41.60M | 3 | 2010-08-17 |
| SENORX INC (SENO) Delisted | 10%+ Owner | 2,193,768 | — | — | -$1.50M | 1 | 2010-04-28 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 4,673,567 | — | — | -$127.0K | 1 | 2009-12-29 |
| Pharmasset Inc (VRUS) Delisted | 10%+ Owner | 8,473 | — | — | -$84.51M | 2 | 2008-06-23 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | 3,846,599 | $1.95 | $7.50M | $0 | 2 | 2007-02-15 |
Recent Filings · Page 2 of 2
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-28 | SENORX INC (SENO) Delisted | Sell (S) | −149,000 | -$1.50M | EDGAR |
| 2009-12-29 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Sell (S) | −36,000 | -$127.0K | EDGAR |
| 2009-02-25 | ReShape Weightloss Inc. (ETRM) Delisted | Buy (P) | +10,592,994 | $12.18M | EDGAR |
| 2008-11-17 | ARYx Therapeutics, Inc. (ARYX) Delisted | Buy (P) | +10,726,260 | $23.60M | EDGAR |
| 2008-06-23 | Pharmasset Inc (VRUS) Delisted | Sell (S) | −1,402,200 | -$27.91M | EDGAR |
| 2008-06-18 | Pharmasset Inc (VRUS) Delisted | Sell (S) | −2,811,490 | -$56.61M | EDGAR |
| 2007-11-13 | ARYx Therapeutics, Inc. (ARYX) Delisted | Mixed | +21,461,172 | $18.00M | EDGAR |
| 2007-02-15 | CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Other (J) | +723 | $0 | EDGAR |
| 2007-02-14 | CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Other (J) | −10,000,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.